NASDAQ · BLLNHealthcareMedical Labs

BillionToOne financials

$118.18−2.91%
Close Sep 29, 2026 · split-adjusted

Revenue

Net income

Income statement & cash flow

Fiscal yearFY25
Dec 31
Revenue$305.1M
Gross profit$208.5M
Gross margin68.3%
Operating income$16.0M
Net income$2.9M
Net margin1.0%
Diluted EPS$0.14
EBITDA$22.9M
Operating cash flow$24.6M
Free cash flow$15.7M
Diluted shares21.2M

Balance sheet

Period endDec 31
Cash & equivalents$496.0M
Short-term investments$0.00
Total debt$58.1M
Total assets$632.7M
Total liabilities$152.5M
Shareholders' equity$480.1M

From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology